X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (556) 556
carnosine (346) 346
animals (331) 331
humans (288) 288
male (280) 280
carnosine - therapeutic use (205) 205
carnosine - pharmacology (185) 185
rats (185) 185
carnosine - analogs & derivatives (174) 174
oxidative stress (144) 144
female (132) 132
pharmacology & pharmacy (121) 121
histidine (110) 110
antioxidants (102) 102
mice (101) 101
biochemistry & molecular biology (96) 96
carnosine - administration & dosage (88) 88
middle aged (85) 85
adult (71) 71
brain (67) 67
analysis (64) 64
organometallic compounds - therapeutic use (64) 64
l-carnosine (61) 61
oxidative stress - drug effects (60) 60
aged (58) 58
carnosine - metabolism (57) 57
dietary supplements (55) 55
dose-response relationship, drug (55) 55
amino acids (53) 53
neurosciences (53) 53
metabolism (52) 52
zinc (52) 52
anserine (51) 51
disease models, animal (50) 50
rats, sprague-dawley (50) 50
rats, wistar (49) 49
physiological aspects (48) 48
inflammation (47) 47
proteins (47) 47
rodents (47) 47
apoptosis (46) 46
cell biology (45) 45
antioxidants - pharmacology (44) 44
biochemistry, general (43) 43
cells (43) 43
diabetes (43) 43
carnosine - chemistry (42) 42
polaprezinc (42) 42
expression (41) 41
zinc compounds (41) 41
enzymes (40) 40
health aspects (40) 40
peptides (40) 40
homocarnosine (39) 39
life sciences (39) 39
antioxidants - therapeutic use (38) 38
antioxidant (37) 37
physiology (37) 37
research article (37) 37
research (36) 36
anti-ulcer agents - therapeutic use (35) 35
damage (35) 35
lipid-peroxidation (34) 34
medicine, research & experimental (34) 34
treatment outcome (33) 33
zinc compounds - therapeutic use (33) 33
cancer (32) 32
care and treatment (32) 32
lipid peroxidation (32) 32
medicine (31) 31
muscle (31) 31
exercise (30) 30
multidisciplinary sciences (30) 30
oncology (30) 30
administration, oral (29) 29
lipid peroxidation - drug effects (29) 29
organometallic compounds - pharmacology (29) 29
time factors (29) 29
toxicology (29) 29
double-blind method (28) 28
glucose (28) 28
ischemia (28) 28
liver (28) 28
prevention (28) 28
skeletal-muscle (28) 28
antioxidant activity (27) 27
cataract - drug therapy (27) 27
metabolites (27) 27
nutrition & dietetics (27) 27
protein (27) 27
studies (27) 27
supplementation (27) 27
biochemistry (26) 26
brain - metabolism (26) 26
muscles (26) 26
plasma (26) 26
toxicity (26) 26
aging (25) 25
article (25) 25
disease (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (620) 620
Russian (29) 29
Japanese (15) 15
Chinese (5) 5
German (4) 4
Czech (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Anticancer Research, ISSN 0250-7005, 08/2018, Volume 38, Issue 8, pp. 4691 - 4697
Journal Article
Anticancer Research, ISSN 0250-7005, 12/2014, Volume 34, Issue 12, pp. 7271 - 7277
Journal Article
Nutrients, ISSN 2072-6643, 05/2015, Volume 7, Issue 5, pp. 3783 - 3795
Background: In hemodialysis (HD) patients, zinc depletion caused by inadequate intake, malabsorption, and removal by HD treatment leads to... 
Erythropoiesis stimulating agent | Zinc deficiency | Hemodialysis | Erythropoietin responsiveness index | Renal anemia | MORTALITY | IMPACT | NUTRITION & DIETETICS | PLASMA | INSULIN-RESISTANCE | INFLAMMATION | STAGE | DISEASE | IRON | ANEMIA | ATHEROSCLEROSIS RISK | Erythropoietin - pharmacology | Multivariate Analysis | Trace Elements - blood | Anemia - blood | Erythropoietin - therapeutic use | Copper - blood | Humans | Middle Aged | Trace Elements - therapeutic use | Anemia - prevention & control | Male | Carnosine - therapeutic use | Trace Elements - pharmacology | Dose-Response Relationship, Drug | Carnosine - analogs & derivatives | Ferritins - blood | Zinc Compounds - pharmacology | Epoetin Alfa - therapeutic use | Organometallic Compounds - therapeutic use | Female | Epoetin Alfa - pharmacology | Erythropoietin - metabolism | Zinc Compounds - therapeutic use | Anemia - etiology | Iron - blood | Trace Elements - deficiency | Administration, Oral | Hemoglobins - metabolism | Carnosine - pharmacology | Zinc - therapeutic use | Kidney Failure, Chronic - therapy | Epoetin Alfa - metabolism | Regression Analysis | Kidney Failure, Chronic - blood | Renal Dialysis - adverse effects | Aged | Zinc - pharmacology | Zinc - blood | Dietary Supplements | Organometallic Compounds - pharmacology | Zinc - deficiency | Index Medicus | hemodialysis | erythropoiesis stimulating agent | renal anemia | zinc deficiency | erythropoietin responsiveness index
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 06/2012, Volume 166, Issue 4, pp. 1344 - 1356
BACKGROUND AND PURPOSE Lipoxidation‐derived reactive carbonyl species (RCS) such as 4‐hydroxy‐2‐nonenal (HNE) react with proteins to form advanced lipoxidation... 
atherosclerosis | carnosine | advanced lipoxidation end products | 4‐hydroxy‐2‐nonenal | reactive carbonyl species | renal disease | 4-hydroxy-2-nonenal | ANTIOXIDANT ACTIVITY | LEUCINE REPEAT | APOPTOSIS | RECEPTOR-MEDIATED MECHANISMS | GENE CNDP1 | LIPOXIDATION | INJURY | PHARMACOLOGY & PHARMACY | E-DEFICIENT MICE | END-PRODUCTS | ASSOCIATION | Free Radical Scavengers - pharmacology | Kidney - pathology | Muscle, Smooth, Vascular - immunology | Carnosine - therapeutic use | Prodrugs - chemistry | Aorta - metabolism | Apolipoproteins E - metabolism | Carnosine - analogs & derivatives | Kidney - metabolism | Free Radical Scavengers - therapeutic use | Renal Insufficiency - immunology | Muscle, Smooth, Vascular - drug effects | Atherosclerosis - pathology | Atherosclerosis - immunology | Kidney - drug effects | Macrophages - pathology | Mesangial Cells - immunology | Aorta - immunology | Mesangial Cells - metabolism | Atherosclerosis - metabolism | Mice, Knockout | Aorta - pathology | Macrophages - metabolism | Mice | Oxidative Stress - drug effects | Carnosine - chemistry | Muscle, Smooth, Vascular - metabolism | Free Radical Scavengers - chemistry | Stereoisomerism | Kidney - immunology | Diet, Atherogenic - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Renal Insufficiency - prevention & control | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Mesangial Cells - drug effects | Female | Macrophages - immunology | Cell Line | Aorta - drug effects | Mice, Inbred C57BL | Cells, Cultured | Renal Insufficiency - metabolism | Carnosine - pharmacology | Muscle, Smooth, Vascular - pathology | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Renal Insufficiency - pathology | Apolipoproteins E - genetics | Mesangial Cells - pathology | Macrophages - drug effects | Prodrugs - therapeutic use | Prodrugs - pharmacology | Atherosclerosis - prevention & control | Kidney diseases | Rodents | Atherosclerosis | Apoptosis | Index Medicus | Research Papers
Journal Article
Anticancer Research, ISSN 0250-7005, 11/2018, Volume 38, Issue 11, pp. 6367 - 6373
Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 02/2015, Volume 127, Issue 2, pp. 223 - 228
Ca 3.2 T-type Ca channels targeted by H S, a gasotransmitter, participate in cyclophosphamide-induced cystitis and bladder pain. Given that zinc selectively... 
Polaprezinc | Bladder pain | T-type Ca2+ channel | Antioxidant activity | Cyclophosphamide-induced cystitis | channel | T-type Ca | GASTRIC-MUCOSAL INJURY | INVOLVEMENT | RATS | HYDROGEN-SULFIDE | INHIBITION | CALCIUM-CHANNELS | ZINC-L-CARNOSINE | INFLAMMATION | ANTIOXIDANT | PHARMACOLOGY & PHARMACY | HYPERALGESIA |